USA fulfillment
Orders ship from our domestic facility with clear tracking once released.
performance research
CJC-1295 + DAC
DAC-modified GHRH analog for endocrine and peptide signaling research · 99%+ purity · COA certified · Research use only
Certified COAUSA manufacturedShips fastResearch use only
$150.00/ 10mg
Select dosage
Volume discounts
1
In stock — ships from our USA facility
- 100% quality guaranteed
- USA fulfillment with tracking
- Certificate of analysis included
For research use only · Not for human consumption
Product description
DAC-modified GHRH analog for endocrine and peptide signaling research
CJC-1295 + DAC is supplied as research-use-only lyophilized material with product education, batch documentation, and dosage-specific SKU tracking.
Handling & storage
CJC-1295 + DAC is a synthetic growth hormone-releasing hormone (GHRH) analog incorporating a Drug Affinity Complex (DAC), supplied for controlled laboratory and analytical research. It is studied in experimental models investigating GHRH receptor activity, endocrine signaling, peptide-receptor interactions, and the biological characteristics of modified peptide analogs. The DAC modification is a key area of research interest because it changes the pharmacokinetic characteristics of the peptide compared with non-DAC variants. This allows researchers to investigate how structural modifications influence peptide stability, binding characteristics, duration of biological activity, and receptor-mediated signaling under controlled experimental conditions. Laboratory investigations involving CJC-1295 + DAC may examine GHRH receptor-mediated signaling, endocrine pathway interactions, growth hormone-associated biology, peptide pharmacokinetics, and structure-function relationships. These areas represent experimental research applications and should not be interpreted as established therapeutic effects. CJC-1295 + DAC is supplied as a lyophilized research material with batch-specific analytical documentation available for applicable manufacturing lots. Researchers should reference the corresponding Certificate of Analysis for reported identity, purity, and other available analytical specifications. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption. Not intended for diagnostic, therapeutic, or clinical use.
Research use only. Not for human or veterinary consumption. Intended for qualified laboratory research.
Product specifications
- Strength
- 10mg
- Form
- Lyophilized powder
- Batch
- K68WPF
- Use
- Research use only
Product description
DAC-modified GHRH analog for endocrine and peptide signaling research
CJC-1295 + DAC is supplied as research-use-only lyophilized material with product education, batch documentation, and dosage-specific SKU tracking.
Handling & storage
CJC-1295 + DAC is a synthetic growth hormone-releasing hormone (GHRH) analog incorporating a Drug Affinity Complex (DAC), supplied for controlled laboratory and analytical research. It is studied in experimental models investigating GHRH receptor activity, endocrine signaling, peptide-receptor interactions, and the biological characteristics of modified peptide analogs. The DAC modification is a key area of research interest because it changes the pharmacokinetic characteristics of the peptide compared with non-DAC variants. This allows researchers to investigate how structural modifications influence peptide stability, binding characteristics, duration of biological activity, and receptor-mediated signaling under controlled experimental conditions. Laboratory investigations involving CJC-1295 + DAC may examine GHRH receptor-mediated signaling, endocrine pathway interactions, growth hormone-associated biology, peptide pharmacokinetics, and structure-function relationships. These areas represent experimental research applications and should not be interpreted as established therapeutic effects. CJC-1295 + DAC is supplied as a lyophilized research material with batch-specific analytical documentation available for applicable manufacturing lots. Researchers should reference the corresponding Certificate of Analysis for reported identity, purity, and other available analytical specifications. For research use only. Keep lyophilized material protected from light, moisture, and temperature excursions. Follow institutional SOPs, product documentation, and the applicable Certificate of Analysis for storage, handling, preparation, and disposal. Not for human or veterinary consumption. Not intended for diagnostic, therapeutic, or clinical use.
Research use only. Not for human or veterinary consumption. Intended for qualified laboratory research.
Product specifications
- Strength
- 10mg
- Form
- Lyophilized powder
- Batch
- K68WPF
- Use
- Research use only
Certificate of analysis
This batch's lab report
Independently tested. Every batch you receive matches the documentation below.
HPLC verified batch
Independent verification for this lot. Purity and endotoxin certificates document what is in your vial.
View full PDF
USA-manufactured · COA on every batch · Research use only
Shipping & compliance
How we fulfill research orders
Batch documentation
Eligible lots include certificate-of-analysis context near the product decision.
Research use only
Not for human or veterinary consumption, diagnosis, treatment, or clinical use.
Qualified buyers
Built for laboratories, institutions, and approved research organizations.
Common questions
About this product
What is CJC-1295 + DAC commonly studied for?
CJC-1295 with Drug Affinity Complex (DAC) is investigated in laboratory research involving growth hormone-releasing hormone (GHRH) receptor signaling, growth hormone-associated pathways, endocrine signaling, and peptide pharmacokinetics. The DAC modification is of particular research interest because it alters the peptide's pharmacokinetic properties compared with non-DAC variants.
What does DAC mean in CJC-1295 + DAC?
DAC stands for Drug Affinity Complex. In research settings, this modification is studied for its effect on the peptide's binding and pharmacokinetic characteristics, including its extended activity compared with shorter-acting CJC-related compounds.
What physical form does CJC-1295 + DAC come in?
CJC-1295 + DAC is supplied as a lyophilized (freeze-dried) powder in a research vial. Refer to the vial label, product specifications, and corresponding batch documentation for the exact quantity and analytical specifications.
Where can I review batch testing?
Available batch-specific testing and Certificate of Analysis (COA) documentation can be reviewed with the corresponding manufacturing lot information.
Is CJC-1295 + DAC for human consumption?
No. This product is labeled Research Use Only (RUO) and is intended exclusively for lawful laboratory research and analytical purposes. It is not intended for human or veterinary consumption, administration, therapeutic use, diagnosis, treatment, or clinical application.
Complete your research
Researchers also bought
CJC-1295 + Ipamorelin
10mg vial
$65View details
Hexarelin
10mg vial
$82View details
IGF-1 LR3
1mg vial
$85View details